Floatz logo

Rotigotine

Right Hemisphere Stroke

University College, LondonSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

133 Active assets in the Right Hemisphere Stroke cohort.

Asset / SponsorPhaseRating
INCOBOTULINUMTOXINA
Parc de Salut Mar
Phase 4BBB
Aggrenox
Boehringer Ingelheim
Phase 4BBB
ATENOLOL
Northern California Institute of Research and Education
Phase 4BBB
Dextromethorphan
University of Florida
Phase 4BBB
Nerinetide
NoNO Inc.
Phase 3BBB

View all 50 →

Same molecule, other indications

Rotigotine is also rated in:

Parkinson diseaseDormant
BBB
Indicative ·
74 / 100
View asset →
Nocturnal HypokinesiaDormant
BB
Indicative ·
65 / 100
View asset →
anxiety disorderDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →